• English
  • 简体中文
Login Register
Current Location: Home > Feedback Help Print

【结 构 式】

【分子编号】36170

【品名】4-oxopentanoic acid

【CA登记号】123-76-2

【 分 子 式 】C5H8O3

【 分 子 量 】116.11672

【元素组成】C 51.72% H 6.94% O 41.34%

与该中间体有关的原料药合成路线共 8 条

合成路线1

该中间体在本合成路线中的序号:(IV)

The phenylhydrazone of benzaldehyde (I) is obtained in the usual way, phenylhydrazine (A) with benzaldehyde (B), which by reaction with benzoyl chloride (II) gives (C) and further treatment with HCl in an organic solvent results in the substituted hydrazine hydrochloride (III). Finally, this compound is condensed with levulinic acid (IV) at high temperature.

1 Francia, E.; Marin, A. (Uriach & Cia S.A.); Procedimiento de obtencion del acido 1-benzoil-2-metilindol-3-acetico. ES 471436 .
2 Francia, E.; Garcia Rafanell, J.; Delmetacin. Drugs Fut 1983, 8, 9, 764.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(B) 10498 Benzaldehyde;Benzoic aldehyde;Phenylmethanal 100-52-7 C7H6O 详情 详情
(A) 11818 Phenyl hydrazine; 1-Phenylhydrazine 100-63-0 C6H8N2 详情 详情
(I) 36167 benzaldehyde N-phenylhydrazone 588-64-7 C13H12N2 详情 详情
(II) 10463 Benzoyl chloride 98-88-4 C7H5ClO 详情 详情
(III) 36169 N-phenylbenzohydrazide C13H12N2O 详情 详情
(IV) 36170 4-oxopentanoic acid 123-76-2 C5H8O3 详情 详情
(C) 36168 N-phenyl-N'-[(E)-benzylidene]benzohydrazide C20H16N2O 详情 详情

合成路线2

该中间体在本合成路线中的序号:(XLII)

In a related strategy, the bromination of levulinic acid (XLII) in MeOH yielded the 3-bromo (XLIV) and 5-bromo (XLIII) esters, which could be separated by distillation. Condensation of methyl 5-bromolevulinate (XLIII) with potassium phthalimide (XXVII) provided methyl phthalimido levulinate (XLV), which was finally hydrolyzed under the same conditions as above for analogous the ethyl ester.

1 Benedikt, E.; Kost, H.-P.; Synthesis of 5-aminolevulinic acid. Z Naturforsch B Anorg Chem Org Chem 1986, 41B, 12, 1593.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XXVII) 27890 Potassium phthalimide 1074-82-4 C8H4KNO2 详情 详情
(XLII) 36170 4-oxopentanoic acid 123-76-2 C5H8O3 详情 详情
(XLIII) 59170 methyl 5-bromo-4-oxopentanoate C6H9BrO3 详情 详情
(XLIV) 59169 methyl 3-bromo-4-oxopentanoate C6H9BrO3 详情 详情
(XLV) 59171 methyl 5-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-4-oxopentanoate C14H13NO5 详情 详情

合成路线3

该中间体在本合成路线中的序号:(XLII)

In a variation of the earlier methods, methyl 5-bromolevulinate (XLIII) was prepared by bromination of levulinic acid (XLII) in methanol. Reaction of bromo ketone (XLIII) with NaN3 in cold DMF provided azide (LXXV). Simultaneous azide reduction and methyl ester hydrolysis was then accomplished by catalytic hydrogenation in the presence of HCl. A further related method consisted in the alkylation of sodium diformylamide (LXXVI) with methyl 5-bromolevulinate (XLIII) in several different solvents to afford the N,N-diformylamino ester (LXXVII), which was finally hydrolyzed under acidic conditions.

1 Moens, L.; Synthesis of delta-aminolevulinic acid. ACS Symp Ser 2001, 784, 37.
2 Ha, H.-J.; et al.; Selective bromination of ketones. A convenient synthesis of 5-aminolevulinic acid. Synth Commun 1994, 24, 18, 2557.
3 Moens, L.; Synthesis of an acid addition salt of delta-aminolevulinic acid from 5-bromo levulinic acid esters. US 5907058 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XLII) 36170 4-oxopentanoic acid 123-76-2 C5H8O3 详情 详情
(XLIII) 59170 methyl 5-bromo-4-oxopentanoate C6H9BrO3 详情 详情
(LXXV) 59197 methyl 5-azido-4-oxopentanoate C6H9N3O3 详情 详情
(LXXVI) 59198 Diformylimide Sodium salt; Sodium diformylamide 18197-26-7 C2H2NNaO2 详情 详情
(LXXVII) 59199 5-(diformylamino)-4-oxopentanoic acid C7H9NO5 详情 详情

合成路线4

该中间体在本合成路线中的序号:(II)

The reaction of phenol (I) with 4-oxopentanoic acid (II) by means of H2SO4 gives 4,4-bis(4-hydroxyphenyl)pentanoic acid (III), which is esterified with MeOH and H2SO4 to yield the methyl pentanoate (IV). The condensation of (IV) with 2-(chloromethyl)quinoline (V) by means of K2CO3 in DMF affords the adduct (VI), which is finally hydrolyzed with NaOH in methanol/dioxane to provide the target sodium salt. Alternatively, the intermediate methyl pentanoate (IV) can also be obtained by direct condensation of phenol (I) with methyl 4-oxopentanoate (VII) by means of H2SO4 as before.

1 Gunn, D.E.; Bhatia, P.; Kolasa, T.; et al.; Symmetrical bis(heteroarylmethoxyphenyl)alkylcarboxylic acids as inhibitors of leukotriene biosynthesis. J Med Chem 2000, 43, 17, 3322.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 23540 Phenol 108-95-2 C6H6O 详情 详情
(II) 36170 4-oxopentanoic acid 123-76-2 C5H8O3 详情 详情
(III) 22391 4,4-bis(4-hydroxyphenyl)pentanoic acid 126-00-1 C17H18O4 详情 详情
(IV) 22392 methyl 4,4-bis(4-hydroxyphenyl)pentanoate C18H20O4 详情 详情
(V) 13162 2-(Chloromethyl)quinoline; alpha-Chloroquinaldine 4377-41-7 C10H8ClN 详情 详情
(VI) 22394 methyl 4,4-bis[4-(2-quinolinylmethoxy)phenyl]pentanoate C38H34N2O4 详情 详情
(VII) 50960 Methyl levulinate C6H10O3 详情 详情

合成路线5

该中间体在本合成路线中的序号:(IX)

Glycosylation of sugar (I) with the idopyranosyl fluoride (II) by means of BF3.Et2O and molecular sieves in dichloromethane gives the disaccharide fragment (III), which is then converted into acetonide (V) by saponification of the ester functions with t-BuOK, followed by reaction with 2,2-dimethoxypropane (IV) in DMF and acidification with p-toluensulfonic acid. Methylation of acetonide (V) with MeI and NaH in DMF/MeOH provides the disaccharide (VI), which is then treated with HOAc to yield the 4',6'-diol (VII). Selective silylation of the diol (VII) with tert-butyldimethylsilyl chloride (TBDMSCl) in pyridine leads to the 6'-O-TBDMS derivative (VIII), which is condensed with levulinic acid (IX) by means of dicyclohexylcarbodiimide (DCC) and 4-dimethylaminopyridine (DMAP) in dioxane to give the ester (X). Compound (X) is then submitted to simultaneous Jones oxidation and TBDMS removal with CrO3 and H2SO4/H2O in acetone to provide the iduronic acid derivative (XI), which is converted into the key intermediate (XII), first by esterification with MeI and KHCO3 in DMF and then by removal of the 4'-O-levulinoyl protecting group with HOAc and hydrazine hydrate in pyridine.

1 del Fresno, M.; Diaz-Ricart, M.; Idraparinux Sodium. Drugs Fut 2002, 27, 7, 639.
2 Basten, J.E.M.; van Boeckel, C.A.A.; Westerduin, P.; et al.; Feasible synthesis and biological properties of six "non-glycosamino" glycan analogues of the antithrombin III binding heparin pentasaccharide. Bioorg Med Chem 1994, 2, 11, 1267.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 54143 (2R,3S,4S,5R,6S)-4,5-bis(benzyloxy)-2-[(benzyloxy)methyl]-6-methoxytetrahydro-2H-pyran-3-ol n/a C28H32O6 详情 详情
(II) 54144 (2S,3S,4S,5R)-5-(acetyloxy)-2-[(acetyloxy)methyl]-6-fluoro-4-methoxytetrahydro-2H-pyran-3-yl acetate n/a C13H19FO8 详情 详情
(III) 54145 (2R,3R,4S,5S,6S)-5-(acetyloxy)-6-[(acetyloxy)methyl]-2-({(2R,3S,4R,5R,6S)-4,5-bis(benzyloxy)-2-[(benzyloxy)methyl]-6-methoxytetrahydro-2H-pyran-3-yl}oxy)-4-methoxytetrahydro-2H-pyran-3-yl acetate n/a C41H50O14 详情 详情
(IV) 10722 1-Methoxy-1-methylethyl methyl ether; 2,2-Dimethoxypropane 77-76-9 C5H12O2 详情 详情
(V) 54146 (4aS,6R,7R,8R,8aS)-6-({(2R,3S,4R,5R,6S)-4,5-bis(benzyloxy)-2-[(benzyloxy)methyl]-6-methoxytetrahydro-2H-pyran-3-yl}oxy)-8-methoxy-2,2-dimethylhexahydropyrano[3,2-d][1,3]dioxin-7-ol n/a C38H48O11 详情 详情
(VI) 54147 (4aS,6R,7R,8R,8aS)-6-({(2R,3S,4R,5R,6S)-4,5-bis(benzyloxy)-2-[(benzyloxy)methyl]-6-methoxytetrahydro-2H-pyran-3-yl}oxy)-7-methoxy-2,2-dimethylhexahydropyrano[3,2-d][1,3]dioxin-8-yl methyl ether; (4aS,6R,7R,8R,8aS)-6-({(2R,3S,4R,5R,6S)-4,5-bis(benzyloxy)-2-[(benzyloxy)methyl]-6-methoxytetrahydro-2H-pyran-3-yl}oxy)-7,8-dimethoxy-2,2-dimethylhexahydropyrano[3,2-d][1,3]dioxine n/a C39H50O11 详情 详情
(VII) 54148 (2S,3S,4S,5R,6S)-6-({(2R,3S,4R,5R,6S)-4,5-bis(benzyloxy)-2-[(benzyloxy)methyl]-6-methoxytetrahydro-2H-pyran-3-yl}oxy)-2-(hydroxymethyl)-4,5-dimethoxytetrahydro-2H-pyran-3-ol n/a C36H46O11 详情 详情
(VIII) 54149 (2S,3S,4S,5R,6S)-6-({(2R,3S,4R,5R,6S)-4,5-bis(benzyloxy)-2-[(benzyloxy)methyl]-6-methoxytetrahydro-2H-pyran-3-yl}oxy)-2-({[tert-butyl(dimethyl)silyl]oxy}methyl)-4,5-dimethoxytetrahydro-2H-pyran-3-ol n/a C42H60O11Si 详情 详情
(IX) 36170 4-oxopentanoic acid 123-76-2 C5H8O3 详情 详情
(X) 54150 (2S,3S,4R,5R,6R)-6-({(2R,3S,4R,5R,6S)-4,5-bis(benzyloxy)-2-[(benzyloxy)methyl]-6-methoxytetrahydro-2H-pyran-3-yl}oxy)-2-({[tert-butyl(dimethyl)silyl]oxy}methyl)-4,5-dimethoxytetrahydro-2H-pyran-3-yl 4-oxopentanoate n/a C47H66O13Si 详情 详情
(XI) 54151 (2R,3S,4R,5R,6R)-6-({(2R,3S,4R,5R,6S)-4,5-bis(benzyloxy)-2-[(benzyloxy)methyl]-6-methoxytetrahydro-2H-pyran-3-yl}oxy)-4,5-dimethoxy-3-[(4-oxopentanoyl)oxy]tetrahydro-2H-pyran-2-carboxylic acid n/a C41H50O14 详情 详情
(XII) 54152 methyl (2R,3S,4S,5R,6R)-6-({(2R,3S,4R,5R,6S)-4,5-bis(benzyloxy)-2-[(benzyloxy)methyl]-6-methoxytetrahydro-2H-pyran-3-yl}oxy)-3-hydroxy-4,5-dimethoxytetrahydro-2H-pyran-2-carboxylate n/a C37H46O12 详情 详情

合成路线6

该中间体在本合成路线中的序号:(IX)

The L-ioduronic acid methyl ester derivative (XII) is then converted into its D-glucuronic acid methyl ester counterpart (XIII) by epimerization with NaOMe in refluxing MeOH, followed by esterification with MeI and KHCO3 in DMF. Protection of the ester (XIII) with levulinic acid (IX) by means of DCC and DMAP in dioxane, followed by acetolysis of the anomeric center with sulfuric acid in acetic anhydride furnishes the disaccharide (XIV), which is then saponified with piperidine and subjected to reaction with trichloroacetonitrile and Cs2CO3 in THF to yield the imidate (XV). Glycosylation of the disaccharide (XII) with the imidate (XV) by means of trimethylsilyl triflate in CH2Cl2, followed by removal of the levulinoyl group by means of hydrazine acetate, furnishes the tetrasaccharide (XVI), which is coupled with the glucosyl trichloroacetimidate (XVIII) by means of trimethylsilyl trifluoromethanesulfonate in CH2Cl2 providing the pentasaccharide (XVII). Glucosyl imidate (XVIII) is prepared by methylation of 1,6-anhydroglucose (XIX) with MeI and NaH in DMF, followed by acetolysis with Ac2O/TFA to give compound (XX), which is treated with piperidine in THF and finally with trichloroacetonitrile in dichloromethane in the presence of Cs2CO3. The pentasaccharide (XVII) is deprotected by saponification with LiOH in THF/H2O2, and then hydrogenated over Pd/C in tert-butanol/water to provide a fully deprotected pentamer, which is finally subjected to sulfation with triethylamine sulfur trioxide complex in DMF and converted into the corresponding sodium salt by elution in a Dowex 50 XW4-Na+ or a Mono-Q anion-exchange column.

1 del Fresno, M.; Diaz-Ricart, M.; Idraparinux Sodium. Drugs Fut 2002, 27, 7, 639.
2 Basten, J.E.M.; van Boeckel, C.A.A.; Westerduin, P.; et al.; Feasible synthesis and biological properties of six "non-glycosamino" glycan analogues of the antithrombin III binding heparin pentasaccharide. Bioorg Med Chem 1994, 2, 11, 1267.
3 van Boeckel, C.A.A.; Petitou, M. (Akzo Nobel N.V.; Sanofi-Synthelabo); Carbohydrate derivs. comprising a trisaccharide unit. EP 0454220; JP 1992225994; US 5378829; US 5382570; US 5529985; US 5773605 .
4 Petitou, M.; van Boeckel, C.A.A. (Akzo Nobel N.V.; Sanofi-Synthelabo); Sulfated glycosaminoglycanoid derivs.. EP 0529715 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(IX) 36170 4-oxopentanoic acid 123-76-2 C5H8O3 详情 详情
(XII) 54152 methyl (2R,3S,4S,5R,6R)-6-({(2R,3S,4R,5R,6S)-4,5-bis(benzyloxy)-2-[(benzyloxy)methyl]-6-methoxytetrahydro-2H-pyran-3-yl}oxy)-3-hydroxy-4,5-dimethoxytetrahydro-2H-pyran-2-carboxylate n/a C37H46O12 详情 详情
(XIII) 54153 vmethyl (2S,3S,4S,5R,6R)-6-({(2R,3S,4R,5R,6S)-4,5-bis(benzyloxy)-2-[(benzyloxy)methyl]-6-methoxytetrahydro-2H-pyran-3-yl}oxy)-3-hydroxy-4,5-dimethoxytetrahydro-2H-pyran-2-carboxylate n/a C37H46O12 详情 详情
(XIV) 54154 methyl (2S,3S,4R,5R,6R)-6-{[(2R,3R,4R,5R)-4,6-bis(acetyloxy)-2-[(acetyloxy)methyl]-5-(benzyloxy)tetrahydro-2H-pyran-3-yl]oxy}-4,5-dimethoxy-3-[(4-oxopentanoyl)oxy]tetrahydro-2H-pyran-2-carboxylate n/a C33H44O17 详情 详情
(XV) 54155 methyl (2S,3S,4R,5R,6R)-6-({(2R,3R,4R,5R)-4-(acetyloxy)-2-[(acetyloxy)methyl]-5-(benzyloxy)-6-[(2,2,2-trichloroethanimidoyl)oxy]tetrahydro-2H-pyran-3-yl}oxy)-4,5-dimethoxy-3-[(4-oxopentanoyl)oxy]tetrahydro-2H-pyran-2-carboxylate n/a C33H42Cl3NO16 详情 详情
(XVI) 54156 methyl (2S,3S,4S,5R,6R)-6-[((2R,3R,4R,5R,6S)-4-(acetyloxy)-2-[(acetyloxy)methyl]-5-(benzyloxy)-6-{[(2R,3S,4R,5R,6R)-6-({(2R,3S,4R,5R,6S)-4,5-bis(benzyloxy)-2-[(benzyloxy)methyl]-6-methoxytetrahydro-2H-pyran-3-yl}oxy)-4,5-dimethoxy-2-(methoxycarbonyl n/a C63H80O25 详情 详情
(XVII) 54158   n/a C74H98O31 详情 详情
(XVIII) 54157 {(2R,3S,4S,5R,6R)-3,4,5-trimethoxy-6-[(2,2,2-trichloroethanimidoyl)oxy]tetrahydro-2H-pyran-2-yl}methyl acetate n/a C13H20Cl3NO7 详情 详情
(XIX) 54159 (1R,2S,3S,4R,5R)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol n/a C6H10O5 详情 详情
(XX) 54160 (3R,4S,5S,6R)-6-[(acetyloxy)methyl]-3,4,5-trimethoxytetrahydro-2H-pyran-2-yl acetate n/a C13H22O8 详情 详情

合成路线7

该中间体在本合成路线中的序号:(XXII)

The nonasaccharide (XX) is transformed into (XXI) by the sequence of benzoate esters hydrolysis, O-methylation, acetal hydrolysis, and selective mono-benzoylation, following the same methods as above. The free hydroxyl group of (XXI) is subsequently protected by esterification with levulinic acid (XXII) to give levulinate ester (XXIII). Opening of the 1,6-anhydroglucose unit of (XXIII) is then accomplished by treatment with acetic anhydride in the presence of acetic acid and trifluoroacetic acid, producing (XXIV).

1 Petitou, M.; Herbert, J.-M.; Duchaussoy, P.; Basten, J.; Dreef-Tromp, C.; Driguez, P.-A.; Van Boeckel, C. (Akzo Nobel N.V.; Sanofi-Synthélabo); Synthetic polysaccharides, their method of production and pharmaceutical compsns. containing same. EP 1049721; FR 2773804; US 6528497; WO 9936443 .
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(XX) 58151   C122H156O51 详情 详情
(XXI) 58152   C86H144O46 详情 详情
(XXII) 36170 4-oxopentanoic acid 123-76-2 C5H8O3 详情 详情
(XXIII) 58153   C91H150O48 详情 详情
(XXIV) 58154   C95H156O51 详情 详情

合成路线8

该中间体在本合成路线中的序号:(I)

 

1 Zbigniew D, Microslaw K, Maria B, et al. 2003. The synthesis and applications of 5-aminoevulinic acid derivatives in photodynamic therapy and photodiagnosis. Acta Poloniae Pharmaceutica, 60(3): 219~224.
中间体序号 中间体编号 品名 CAS号 分子式 供应商 用于合成
(I) 36170 4-oxopentanoic acid 123-76-2 C5H8O3 详情 详情
(II) 59170 methyl 5-bromo-4-oxopentanoate C6H9BrO3 详情 详情
(III) 59171 methyl 5-(1,3-dioxo-1,3-dihydro-2H-isoindol-2-yl)-4-oxopentanoate C14H13NO5 详情 详情
(IV) 67148 5-amino-4-oxopentanoic acid hydrochloride   C5H9NO3.HCl 详情 详情
Extended Information